University Hospitals Birmingham NHS Foundation Trust

Medicines A–Z

M

Status Drug name NICE TAs Comments
Status: Red Mobocertinib (Exkivity®)
Status: Amber Moclobemide tablets

Specialist initiation only
Status: Amber Modafinil tablets

Specialist initiation only. For treatment of narcolepsy only.
Status: Red Mogamulizumab (Poteligeo®)
Status: Green Molnupiravir (Lagevrio®)

For eligible non-hospitalised patients (12 years and over) oral antiviral medicines are provided, following assessment, by Badger Covid Medicines Delivery Unit (CMDU), in line with NICE Technology Appraisal 878 and 1056.
Patients in the community can be referred to the Badger CMDU by their GP or NHS111
Local CMDU service information is available on BSol ICB Primary Care Hub (free registration required for access by general practice in BSol).

COVID-19 community treatment pathway, including eligibility criteria, treatment options and information on referral to Badger CMDU.
COVID-19 Medicines Delivery Unit (CMDU) Referral Form
Relevant national guidance and policy

NICE Technology Appraisal 1056: Molnupiravir for treating COVID-19
COVID-19 rapid guideline: managing COVID-19
Status: Amber Mometasone furoate 0.1% cream
Status: Amber Mometasone furoate 0.1% ointment
Status: Green Mometasone furoate aqueous nasal spray

High relative cost. Second line.
Status: Amber Mometasone furoate scalp lotion
Status: Red Monobenzone 20% in suitable emollient

Unlicensed special
Building healthier lives
Back to top